Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Applications of Clinically Relevant Dissolution Testing: Workshop Summary Report.

Suarez-Sharp S, Cohen M, Kesisoglou F, Abend A, Marroum P, Delvadia P, Kotzagiorgis E, Li M, Nordmark A, Bandi N, Sjögren E, Babiskin A, Heimbach T, Kijima S, Mandula H, Raines K, Seo P, Zhang X.

AAPS J. 2018 Aug 27;20(6):93. doi: 10.1208/s12248-018-0252-3.

PMID:
30151612
2.

Enhancement of tunneling current in phosphorene tunnel field effect transistors by surface defects.

Lu J, Fan ZQ, Gong J, Chen JZ, ManduLa H, Zhang YY, Yang SY, Jiang XW.

Phys Chem Chem Phys. 2018 Feb 21;20(8):5699-5707. doi: 10.1039/c7cp08678d.

PMID:
29410993
3.

Impact of the US FDA "Biopharmaceutics Classification System" (BCS) Guidance on Global Drug Development.

Mehta MU, Uppoor RS, Conner DP, Seo P, Vaidyanathan J, Volpe DA, Stier E, Chilukuri D, Dorantes A, Ghosh T, Mandula H, Raines K, Dhanormchitphong P, Woodcock J, Yu LX.

Mol Pharm. 2017 Dec 4;14(12):4334-4338. doi: 10.1021/acs.molpharmaceut.7b00687. Epub 2017 Nov 7.

PMID:
29076742
4.

Biopharmaceutics classification system-based biowaivers for generic oncology drug products: case studies.

Tampal N, Mandula H, Zhang H, Li BV, Nguyen H, Conner DP.

AAPS PharmSciTech. 2015 Feb;16(1):5-9. doi: 10.1208/s12249-014-0195-7. Epub 2014 Sep 23. Review.

5.

Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin.

Parepally JM, Mandula H, Smith QR.

Pharm Res. 2006 May;23(5):873-81. Epub 2006 May 2.

PMID:
16715377
6.

Role of site-specific binding to plasma albumin in drug availability to brain.

Mandula H, Parepally JM, Feng R, Smith QR.

J Pharmacol Exp Ther. 2006 May;317(2):667-75. Epub 2006 Jan 12.

PMID:
16410405

Supplemental Content

Loading ...
Support Center